DNL-921

N/A

Report date: 2025/03/18 15:32:04

Base Information

Drug NameDNL-921
Drug Alias NameATV-AβATV-Amyloid-βATV Amyloid BetaATV-AbetaATV:Abeta +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-APP
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A